No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr21:46122800-46129400 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr21:46125800-46128400 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
3 |
chr21:46126000-46129000 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
4 |
chr21:46126000-46129400 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
5 |
chr21:46126000-46132600 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
6 |
chr21:46126200-46128600 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
7 |
chr21:46126200-46132000 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
8 |
chr21:46126400-46132800 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
9 |
chr21:46126600-46128200 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
10 |
chr21:46126600-46128600 |
Bivalent/Poised TSS |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
11 |
chr21:46126800-46128200 |
Bivalent Enhancer |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
12 |
chr21:46126800-46129400 |
Weak transcription |
Pancreas |
Pancrea
|
13 |
chr21:46127000-46128600 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
14 |
chr21:46127400-46130000 |
Bivalent Enhancer |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
15 |
chr21:46127400-46131800 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
16 |
chr21:46127400-46132000 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
17 |
chr21:46127600-46129800 |
Bivalent Enhancer |
Primary T killer memory cells from peripheral blood |
blood
|
18 |
chr21:46127600-46130200 |
Bivalent Enhancer |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
19 |
chr21:46127800-46128200 |
Bivalent Enhancer |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
20 |
chr21:46127800-46128400 |
Bivalent Enhancer |
Fetal Brain Male |
brain
|
21 |
chr21:46128000-46128200 |
Bivalent Enhancer |
Fetal Heart |
heart
|
22 |
chr21:46128000-46128200 |
Bivalent Enhancer |
Fetal Lung |
lung
|
23 |
chr21:46128000-46128400 |
Flanking Bivalent TSS/Enh |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
24 |
chr21:46128000-46128400 |
Bivalent Enhancer |
Primary T killer naive cells fromperipheralblood |
blood
|
25 |
chr21:46128000-46128600 |
Flanking Bivalent TSS/Enh |
ES-UCSF4 Cell Line |
embryonic stem cell
|
26 |
chr21:46128000-46128600 |
Bivalent Enhancer |
A549 |
lung
|
27 |
chr21:46128000-46128800 |
Flanking Bivalent TSS/Enh |
HUES48 Cell Line |
embryonic stem cell
|
28 |
chr21:46128000-46129000 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
29 |
chr21:46128000-46129000 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
30 |
chr21:46128000-46129200 |
Bivalent Enhancer |
Breast Myoepithelial Primary Cells |
Breast
|
31 |
chr21:46128000-46129200 |
Bivalent Enhancer |
Primary T helper 17 cells PMA-I stimulated |
--
|
32 |
chr21:46128000-46129200 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
33 |
chr21:46128000-46129200 |
Bivalent Enhancer |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
34 |
chr21:46128000-46129400 |
Bivalent Enhancer |
Left Ventricle |
heart
|